New York, New York, United States Orkila Capital appeared to be the VC, which was created in 2013. The fund was located in North America if to be more exact in United States. The main department of described VC is located in the New York.
Among the most popular portfolio startups of the fund, we may highlight Cannamedical Pharma. For fund there is no match between the location of its establishment and the land of its numerous investments - Germany. Among the most popular fund investment industries, there are Medical, Brewing. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.
The high activity for fund was in 2019. The fund is constantly included in less than 2 deals per year. Deals in the range of 10 - 50 millions dollars are the general things for fund.
The usual cause for the fund is to invest in rounds with 1 partaker.
This organization was formed by Jesse M. Du Bey.
| Fund Name | Location |
| Best1Cruise | Japan, Tokyo |
| Devonshire Ventures, LLC | - |
| Fluid-o-Tech | Corsico, Italy, Lombardy |
| Fu Gao Shi Ye | China, Qingpu, Shanghai |
| Huarui Wanxiang Touzi | Beijing, Beijing, China |
| JVIC VENTURE CAPITAL | Japan, Tokyo |
| New Anglia Capital | Norfolk, Norwich, United Kingdom |
| Peiffer New Solutions | Austria, Oberosterreich, Upper Austria |
| Shenghe Tianmei | China, Guangdong, Shenzhen |
| Xinhua Bookstore | China, Hunan, Liuyang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Cannamedical Pharma | $17M | 31 Jan 2019 | Cologne, North Rhine-Westphalia, Germany |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Cannamedical Pharma | $17M | 31 Jan 2019 | Cologne, North Rhine-Westphalia, Germany |
